Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
576.00    -11.00 (-1.87%)
Bid:
575.00
Ask:
577.00
Spread: 2.00 (0.348%)
Market Cap: £1.06b
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

Trading Update

15 Oct 2020 07:00

RNS Number : 1183C
Volex PLC
15 October 2020
 

15 October 2020

 

Volex plc

("Volex" or the "Company")

 

Trading Update

 

Volex plc (AIM:VLX), the global supplier of integrated manufacturing services and power products, is today issuing a trading update ahead of the scheduled announcement of the group's interim results for the 26 weeks ended 4 October 2020, on 12 November 2020. 

COVID-19

 

We are continuing to monitor the global situation in respect of COVID-19. The health, safety and well-being of our colleagues remain our principal responsibility and we are providing our facilities with our full support, following all public health advice, and complying with all government directives. All manufacturing facilities remained fully operational following adaptations that were made in the first quarter in response to the COVID-19 pandemic.

 

Trading

 

Volex's performance has continued to improve since the group last updated the market at our Annual General Meeting on 30 July 2020.

 

Consequently, the board now expects revenue and profitability to be above current market expectations for both the half-year period and the full year as a whole.

 

· Unaudited revenue for the six months ended 4 October 2020 is expected to be at least $200 million, which represents an increase of 2.2 per cent over the same period a year earlier;

 

· Underlying operating profit is expected to be at least $20 million, which represents an increase of 25.8 per cent over the same period a year earlier;

 

· Net cash excluding lease liabilities as at 2 October 2020 was approximately $31 million.

 

Executive Chairman Nat Rothschild commented:

 

"We enter the final quarter of calendar 2020 in a healthy position. Our geographic and customer diversification continues to provide the business with a high degree of visibility at this time while ongoing demand for consumer electronics remains strong and the global shift to electric vehicles gathers pace.

 

Absent another widespread COVID-19 related global lockdown, given the robust performance in the first half of the year, coupled with our strong forward order book position, the board expects to see a strong performance for the year as a whole that will be above current market expectations.

 

I would like to extend my sincere thanks to the entire Volex team for their invaluable contribution to this strong performance as we look ahead to the second half of the year with cautious optimism." 

 

For further information please contact:

 

Volex plc

+44 (0)7909 995 887

Nat Rothschild, Executive Chairman

 

Daren Morris, Chief Financial Officer

 

 

Powerscourt - Media Enquiries

+44 (0)20 7250 1446

James White

 

Jack Holden

 

 

N+1 Singer - Nominated Adviser & Joint Broker

+44 (0)20 7496 3000

Shaun Dobson

 

Iqra Amin

 

 

Panmure Gordon - Joint Broker

+44 (0)20 7886 2500

Hugh Rich

 

Nick Lovering

 

 

 

NOTES TO EDITORS:

Volex plc (AIM:VLX) is a leading integrated manufacturing specialist. The Group designs and manufactures products that ensure a critical connection never fails and are used in everything from defibrillators and ventilators through to data networking equipment and vehicle telematics. Headquartered in the United Kingdom, Volex serves the needs of its blue-chip customer base from its manufacturing sites located across nine countries and three continents, employing over 6,000 people. Volex's products are sold through its own global sales force and through distributors to Original Equipment Manufacturers ('OEMs') and Electronic Manufacturing Services companies. For more information please visit www.volex.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFEFILESSEIS
Date   Source Headline
7th Oct 20097:00 amRNSTrading Statement
28th Sep 200910:35 amRNSDirector Declaration
9th Sep 20091:31 pmRNSDirector/PDMR Shareholding
4th Aug 200911:56 amRNSAnnual Information Update
3rd Aug 20092:24 pmRNSChange of Registered Office
3rd Aug 200910:32 amRNSDirector Declaration
29th Jul 20095:25 pmRNSResult of AGM
29th Jul 20097:00 amRNSAGM & IMS Statement
27th Jul 20095:48 pmRNSHolding(s) in Company
27th Jul 20093:15 pmRNSHolding(s) in Company
24th Jul 20091:05 pmRNSHolding(s) in Company
29th Jun 20094:05 pmRNSHolding(s) in Company
26th Jun 20094:13 pmRNSHolding(s) in Company
1st Jun 20097:00 amRNSFinal Results
6th May 200911:15 amRNSNotice of Results
30th Apr 20093:50 pmRNSHolding(s) in Company
21st Apr 20093:30 pmRNSHolding(s) in Company
21st Apr 20092:47 pmRNSHolding(s) in Company
20th Apr 20093:17 pmRNSHolding(s) in Company
9th Apr 20099:36 amRNSBlocklisting Interim Review
9th Apr 20099:36 amRNSBlocklisting Interim Review
6th Apr 20097:00 amRNSCompletion of Disposal
31st Mar 20091:49 pmRNSResult of EGM
19th Mar 20091:26 pmRNSDirector/PDMR Shareholding
19th Mar 20097:00 amRNSDirector/PDMR Shareholding
13th Mar 20093:21 pmRNSBanking and Posting Announcement
10th Mar 20097:00 amRNSDirectorate Change
19th Feb 200912:11 pmRNSDirectorate Change
19th Feb 20097:00 amRNSInterim Management Statement
17th Feb 20099:36 amRNSHolding(s) in Company
9th Feb 20094:21 pmRNSProposed Sale
16th Dec 20087:00 amRNSDirectorate Change
8th Dec 20082:55 pmRNSDirectorate Change
5th Dec 20084:21 pmRNSResult of EGM
5th Dec 20083:12 pmRNSHolding(s) in Company
18th Nov 20086:13 pmRNSChange In Director's Details
17th Nov 20087:00 amRNSInterim Results
10th Nov 20089:27 amRNSNotice of EGM
6th Nov 20083:09 pmRNSHolding(s) in Company
23rd Oct 20085:49 pmRNSNotice of request for EGM
20th Oct 20083:23 pmRNSNotice of Results
13th Oct 20084:03 pmRNSDirector Declaration
6th Oct 20083:54 pmRNSHolding(s) in Company
3rd Oct 20083:56 pmRNSHolding(s) in Company
3rd Oct 20083:20 pmRNSBlocklisting Interim Review
3rd Oct 20083:14 pmRNSBlocklisting Interim Review
22nd Sep 20087:00 amRNSStrategic Review and Trading Update
13th Aug 20081:05 pmRNSAnnual Information Update
6th Aug 20083:52 pmRNSHolding(s) in Company
6th Aug 20083:46 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.